Researcher

Dr. Lei PEI received her PhD in Clinical Bacteriology from Karolinska Institute, Stockholm, Sweden. After a postdoc in the Massachusetts General Hospital, USA, in the Flanders Institute for Biotechnology (VIB) at Ghent University, Belgium, she started to focus on synthetic biology at Biofaction where she is in charge of regulatory, IP and biosafety issues.